🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals administering products of unknown origin.

Some experts said the popularity for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Content Elimination

Based on the social media company, the service has taken down violative material and prohibited related keywords and query recommendations. The company stated it was committed to keeping the service secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.

Within moments of joining one group, a vendor shared contact information, where the majority of purchases occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these groups, messages display dark colored packages with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.